BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8091883)

  • 21. [Prevention of thromboembolism with low-molecular-weight heparin in ambulatory surgery and unoperated surgical and orthopedic patients].
    Harenberg J; Piazolo L; Misselwitz F
    Zentralbl Chir; 1998; 123(11):1284-7. PubMed ID: 9880848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low molecular weight heparin for the prevention and treatment of venous thromboembolism.
    Raskob GE
    Curr Opin Pulm Med; 1996 Jul; 2(4):305-10. PubMed ID: 9363157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of deep venous thrombosis by a new low molecular weight heparin (Fluxum) in cardiac surgery.
    Beghi C; Fragnito C; Antonelli A; Reverberi C; Ferrari P; Saccani S; Fesani F
    Int Angiol; 1993 Dec; 12(4):383-6. PubMed ID: 8207317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity].
    Kock HJ; Schmit-Neuerburg KP; Hanke J; Hakmann A; Althoff M; Rudofski G
    Vasa Suppl; 1992; 35():105-6. PubMed ID: 1336215
    [No Abstract]   [Full Text] [Related]  

  • 25. Low-molecular-weight heparin (fraxiparine) to prevent deep vein thrombosis in patients undergoing orthopedic surgery: a clinical report of two regimens.
    Drouet JC; Bernard JM; Bourreli B; Gunst JP
    Haemostasis; 1988; 18(2):135-6. PubMed ID: 2842239
    [No Abstract]   [Full Text] [Related]  

  • 26. [Venous thrombosis. After heparin administration, low-molecular-weight heparin for prevention of recurrence].
    MMW Fortschr Med; 2001 Apr; 143(16):56. PubMed ID: 11367997
    [No Abstract]   [Full Text] [Related]  

  • 27. [Is the prevention of venous thrombosis justified in arterial surgery?].
    Martorell A; Monreal M; Montserrat E; Silveira P; Callejas JM
    Angiologia; 1991; 43(2):51-2, 54. PubMed ID: 2069269
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical experience of a low molecular weight heparin (Fragmin) in the prevention of thromboembolism after total hip replacement.
    Eriksson BI; Kälebo P; Risberg B
    Semin Thromb Hemost; 1993; 19 Suppl 1():122-7. PubMed ID: 8395714
    [No Abstract]   [Full Text] [Related]  

  • 29. [The thromboprophylactic effect of low molecular weight heparin (Fragmin) in hip fracture surgery. A placebo controlled trial].
    Jørgensen PS; Knudsen JB; Broeng L; Josephsen IL; Bjerregaard P; Hagen KK; Jørgensen PK; Tørholm C
    Ugeskr Laeger; 1993 Mar; 155(10):706-8. PubMed ID: 8384388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Extrahepatic portal vein thrombosis following laparoscopic cholecystectomy].
    Rusznak M; Kuttner R; Greim CA
    Chirurg; 2003 Mar; 74(3):244-7. PubMed ID: 12647082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-finding studies of reviparin in elective hip surgery.
    Planès A; Vochelle N; Chevret S; Fagola M; Bellaud M
    Semin Thromb Hemost; 1993; 19 Suppl 1():44-8. PubMed ID: 8395731
    [No Abstract]   [Full Text] [Related]  

  • 32. [Efficient ambulatory and post-discharge thromboprophylaxis with fully automated pens].
    Höntzsch D; Scheffer J; Hafner S
    Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():1060-2. PubMed ID: 9574332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylaxis of venous thromboembolism in surgery.
    Verhaeghe R; Verstraete M
    Acta Chir Belg; 1997 Jun; 97(3):106-9. PubMed ID: 9224512
    [No Abstract]   [Full Text] [Related]  

  • 34. [Is anticoagulation with heparins in phenprocoumon treated patients safe during operations?].
    Hoppe UC
    Dtsch Med Wochenschr; 2002 Nov; 127(44):2345. PubMed ID: 12410442
    [No Abstract]   [Full Text] [Related]  

  • 35. [Low doses of heparin in the prevention of postoperative thrombosis of deep veins of the lower limbs].
    Baeshko AA; Shorokh GP
    Klin Med (Mosk); 1995; 73(5):60-2. PubMed ID: 8815283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of postoperative deep vein thrombosis in cancer patients. A randomized trial with low molecular weight heparin (CY 216).
    Marassi A; Balzano G; Mari G; D'Angelo SV; Della Valle P; Di Carlo V; D'Angelo A
    Int Surg; 1993; 78(2):166-70. PubMed ID: 8394842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ["How must deep leg venous thrombosis be diagnosed and treated?"].
    Bruhn HD
    Dtsch Med Wochenschr; 2003 Aug; 128(33):1730-1. PubMed ID: 12920673
    [No Abstract]   [Full Text] [Related]  

  • 38. When can the patient with deep venous thrombosis begin to ambulate?
    Aldrich D; Hunt DP
    Phys Ther; 2004 Mar; 84(3):268-73. PubMed ID: 14984299
    [No Abstract]   [Full Text] [Related]  

  • 39. Deep venous thrombosis after laparoscopic cholecystectomy and prevention with nadroparin.
    Schaepkens Van Riempst JT; Van Hee RH; Weyler JJ
    Surg Endosc; 2002 Jan; 16(1):184-7. PubMed ID: 11961636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laboratory evaluation of the effect of prophylaxis for thromboembolism with fractionated heparin in patients undergoing laparoscopic cholecystectomy.
    Martínez Ramos C; López Pastor A; Núñez Peña JR; Ruiz de Gopegui M; Sanz López R; Jorgensen T; Pastor L; Tamames S
    Rev Esp Enferm Dig; 2000 Jan; 92(1):27-35. PubMed ID: 10749595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.